Found: 35
Select item for more details and to access through your institution.
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs.
- Published in:
- Diabetologia, 2006, v. 49, n. 4, p. 706, doi. 10.1007/s00125-005-0128-9
- By:
- Publication type:
- Article
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
- Published in:
- Diabetologia, 2005, v. 48, n. 9, p. 1872, doi. 10.1007/s00125-005-1863-7
- By:
- Publication type:
- Article
Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.
- Published in:
- Diabetologia, 2005, v. 48, n. 9, p. 1882, doi. 10.1007/s00125-005-1847-7
- By:
- Publication type:
- Article
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia J.J. Meier et al.: GIP and glucagon secretion.
- Published in:
- Diabetologia, 2003, v. 46, n. 6, p. 798, doi. 10.1007/s00125-003-1103-y
- By:
- Publication type:
- Article
GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 11, p. 990, doi. 10.1111/j.1463-1326.2011.01431.x
- By:
- Publication type:
- Article
Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 9, p. 863, doi. 10.1111/j.1463-1326.2011.01420.x
- By:
- Publication type:
- Article
Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 9, p. 850, doi. 10.1111/j.1463-1326.2011.01417.x
- By:
- Publication type:
- Article
An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 5, p. 394, doi. 10.1111/j.1463-1326.2011.01357.x
- By:
- Publication type:
- Article
Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 4, p. 366, doi. 10.1111/j.1463-1326.2011.01362.x
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review.
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 1, p. 7, doi. 10.1111/j.1463-1326.2010.01306.x
- By:
- Publication type:
- Article
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 4, p. 323, doi. 10.1111/j.1463-1326.2009.01167.x
- By:
- Publication type:
- Article
Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto–Kakizaki rats.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 9, p. 884, doi. 10.1111/j.1463-1326.2009.01066.x
- By:
- Publication type:
- Article
Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 5, p. 595, doi. 10.1111/dme.12622
- By:
- Publication type:
- Article
Comparative review of dipeptidyl peptidase‐4 inhibitors and sulphonylureas.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 4, p. 333, doi. 10.1111/dom.12610
- By:
- Publication type:
- Article
Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 4, p. 333, doi. 10.1111/dom.12610
- By:
- Publication type:
- Article
Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 1, p. 74, doi. 10.1111/dom.12395
- By:
- Publication type:
- Article
Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 ( GLP-1): implications for GLP-1 measurements in clinical studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 11, p. 1155, doi. 10.1111/dom.12352
- By:
- Publication type:
- Article
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 8, p. 762, doi. 10.1111/j.1463-1326.2012.01603.x
- By:
- Publication type:
- Article
Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 8, p. 4888, doi. 10.1210/jc.2004-2460
- By:
- Publication type:
- Article
Measurement of circulating human proinsulin concentrations using a proinsulin-specific antiserum.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Incretin-based therapies - review of the physiology, pharmacology and emerging clinical experience.
- Published in:
- Internal Medicine Journal, 2011, v. 41, n. 4, p. 299, doi. 10.1111/j.1445-5994.2011.02439.x
- By:
- Publication type:
- Article
HYPERSECRETION OF PROINSULIN DOES NOT EXPLAIN THE HYPERINSULINAEMIA OF PATIENTS WITH LIVER CIRRHOSIS.
- Published in:
- Clinical Endocrinology, 1986, v. 25, n. 4, p. 351, doi. 10.1111/j.1365-2265.1986.tb01701.x
- By:
- Publication type:
- Article
The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects.
- Published in:
- European Journal of Endocrinology, 2014, v. 171, n. 3, p. 353, doi. 10.1530/EJE-14-0314
- By:
- Publication type:
- Article
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-α in patients with HIV-lipodystrophy.
- Published in:
- HIV Medicine, 2006, v. 7, n. 3, p. 163, doi. 10.1111/j.1468-1293.2006.00364.x
- By:
- Publication type:
- Article
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 91, doi. 10.1111/j.1468-1293.2005.00270.x
- By:
- Publication type:
- Article
Ghrelin secretion in humans – a role for the vagus nerve?
- Published in:
- Neurogastroenterology & Motility, 2018, v. 30, n. 6, p. 1, doi. 10.1111/nmo.13295
- By:
- Publication type:
- Article
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Conversion of Neuropeptide K to Neurokinin A and Vesicular Colocalization of Neurokinin A and Substance P in Neurons of the Guinea Pig Small Intestine.
- Published in:
- Journal of Neurochemistry, 1987, v. 48, n. 1, p. 141, doi. 10.1111/j.1471-4159.1987.tb13138.x
- By:
- Publication type:
- Article
Proteolytic Inactivation of Substance P and Neurokinin A in the Longitudinal Muscle Layer of Guinea Pig Small Intestine.
- Published in:
- Journal of Neurochemistry, 1986, v. 47, n. 3, p. 856, doi. 10.1111/j.1471-4159.1986.tb00690.x
- By:
- Publication type:
- Article
The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 4, p. 379, doi. 10.1111/j.1365-2036.2012.05198.x
- By:
- Publication type:
- Article